JG
SGNT

Joel Greenblatt’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Joel Greenblatt’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,886
Closed -$499K – 1090
2014
Q4 		$499K Buy
19,886
+13,064
+191% +$383K ﹤0.01% 738
2014
Q3 		$212K Buy
+6,822
New +$185K ﹤0.01% 921
2014
Q2 		– Sell
-21,573
Closed -$504K – 1163
2014
Q1 		$504K Sell
21,573
-17,785
-45% -$389K 0.01% 793
2013
Q4 		$999K Buy
+39,358
New +$889K 0.02% 629

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Joel Greenblatt's SGNT Position: Q1 2015 in Review

Joel Greenblatt sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2015, closing a stake of 19,886 shares — an estimated $499K sold.

Joel Greenblatt first reported a position in SGNT in Q4 2013 and held it in 4 quarters. The position peaked at $999K in Q4 2013. 127 funds tracked by Wall St. Rank hold SGNT as of Q1 2015.

  • Joel Greenblatt reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Joel Greenblatt sold 19,886 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $499K.
  • Joel Greenblatt first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 4 quarters.
  • Joel Greenblatt's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $999K in Q4 2013.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Gotham Asset Management's 13F filing for Q1 2015, filed 15 May 2015.